Title : Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.

Pub. Date : 2015 Jun 15

PMID : 25398450






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib. Lenalidomide CD38 molecule Homo sapiens